On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Revolutionary Technology is Disrupting the Cannabis Edibles Industry

  • Lexaria Bioscience Corp. is the only company worldwide with patents issued for oral delivery of all cannabinoids
  • Its proprietary technology bests traditional methods such as inhalation in several key ways
  • The company continues to enhance its intellectual property portfolio as it pursues patents around the world

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a food biosciences company, has developed a proprietary technology that has revolutionized the way cannabidiol (CBD) and other non-psychoactive cannabinoids are delivered into the bloodstream.

Lexaria, the only company worldwide with patents issued for oral delivery of all cannabinoids, has greatly improved the delivery of bioactive compounds. While cannabinoids typically enter the bloodstream in three main ways, each has its limitations. Inhalation is harmful to the lungs; sub-lingual (under the tongue) consumption carries a bitter taste unless copiously sweetened; and oral consumption is typically is very slow to act, often between one and three hours.

As a disruptor in the cannabis industry, Lexaria’s DehydraTECH drug delivery platform is changing the way cannabinoids enter the bloodstream through the gastrointestinal tract. Its proprietary technology promises multiple advantages in cannabinoid edibles. First, it masks the undesirable taste typically found in cannabinoid edibles, eliminating the need to add sweetening agents and enabling sugar-free options. Second, it increases the product’s absorption rate, with absorption occurring at two- to five-times higher rates than other edibles. Finally, it reduces the time of onset; effects of the product are felt within 15-20 minutes of consumption rather than the typical 60-120 minutes. In a March 2016 focus study, subjects ranked Lexaria’s formulation as the best tasting and most palatable option. They also found it to deliver the highest-quality THC experience overall.

Some of Lexaria’s featured products have included protein energy bars; CBD tablets; exotic teas delivering CBD in multiple flavors; coffee; and TurboCBD capsules, which are described as “high absorption, full spectrum hemp oil capsules aimed to increase focus and memory while also reducing stress and fatigue.”

While Lexaria’s groundbreaking technology has set a new quality standard for other companies to aspire to, the company also takes pride in its pursuance of a strong intellectual property portfolio. By the end of 2018, the company’s portfolio included 53 patent applications pending in over 40 countries worldwide, as well as 10 patents already granted. Anticipating new patent awards in 2019 both in the United States and across the world, Lexaria continues to make inroads into various industries through its research and development and key business relationships.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at www.nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Archives

Select A Month

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217